Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VMD Stock Forecast 2026-2027
$7.33
Current Price
$284.30M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to VMD Price Targets
+104.6%
To High Target of $15.00
+77.4%
To Median Target of $13.00
+50.1%
To Low Target of $11.00
VMD Price Momentum
+0.4%
1 Week Change
-1.2%
1 Month Change
-10.1%
1 Year Change
-1.3%
Year-to-Date Change
-14.9%
From 52W High of $8.62
+23.6%
From 52W Low of $5.93
📊 TOP ANALYST CALLS
Did VMD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Viemed is one of their latest high-conviction picks.
Latest VMD Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, VMD has a bullish consensus with a median price target of $13.00 (ranging from $11.00 to $15.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $7.33, the median forecast implies a 77.4% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VMD Analyst Ratings
2
Buy
0
Hold
0
Sell
VMD Price Target Range
Low
$11.00
Average
$13.00
High
$15.00
Current: $7.33
Latest VMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 3, 2021 | RBC Capital | Frank Morgan | Outperform | Maintains | $9.00 |
| Mar 5, 2021 | RBC Capital | Outperform | Initiates | $N/A |
Viemed Healthcare Inc. (VMD) Competitors
The following stocks are similar to Viemed based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Viemed Healthcare Inc. (VMD) Financial Data
Viemed Healthcare Inc. has a market capitalization of $284.30M with a P/E ratio of 21.6x. The company generates $254.79M in trailing twelve-month revenue with a 5.3% profit margin.
Revenue growth is +24.0% quarter-over-quarter, while maintaining an operating margin of +9.7% and return on equity of +10.7%.
Valuation Metrics
Market Cap
$284.30M
Enterprise Value
$294.13M
P/E Ratio
21.6x
PEG Ratio
-2.2x
Price/Sales
1.1x
Growth & Margins
Revenue Growth (YoY)
+24.0%
Gross Margin
+57.5%
Operating Margin
+9.7%
Net Margin
+5.3%
EPS Growth
-9.4%
Financial Health
Cash/Price Ratio
+4.0%
Current Ratio
1.1x
Debt/Equity
18.2x
ROE
+10.7%
ROA
+6.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Viemed Healthcare Inc. (VMD) Business Model
About Viemed Healthcare Inc.
What They Do
Provides in-home respiratory care services.
Business Model
Viemed Healthcare Inc. operates by delivering personalized healthcare solutions for patients with chronic respiratory conditions, primarily generating revenue through in-home care services like disease management and ventilator therapy. The company ensures continuity of care beyond traditional clinical settings, thereby positioning itself as a vital provider in the home healthcare sector.
Additional Information
Viemed leverages advanced technology and skilled respiratory therapists to optimize patient outcomes. The company addresses the increasing demand for home-based chronic care solutions, particularly for an aging population, making it a significant player in the evolving healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
1,380
CEO
Mr. Casey Hoyt
Country
United States
IPO Year
N/A
Website
www.viemed.comViemed Healthcare Inc. (VMD) Latest News & Analysis
Latest News
Quick Summary
Stonegate Capital Partners has initiated coverage on Viemed Healthcare, Inc. (NASDAQ: VMD) as of January 6, 2026.
Why It Matters
Stonegate Capital Partners initiating coverage on Viemed Healthcare signals potential interest and analysis, which could influence investor sentiment and stock price movements.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Viemed Healthcare, Inc. (VMD) will host its Q3 2025 Earnings Call on November 6, 2025, at 11:00 AM EST, featuring key executives and analysts from various firms.
Why It Matters
The earnings call indicates Viemed Healthcare's financial performance for Q3 2025, providing insights into revenue trends and operational strategies that could impact stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Viemed Healthcare (NASDAQ: VMD) reported record net revenues of $71.9 million for Q3 2025, up 24% from $58 million in Q3 2024, reflecting strong growth in its post-acute respiratory care segment.
Why It Matters
Viemed Healthcare's record revenue growth of 24% signals strong demand and operational success, potentially boosting investor confidence and stock performance.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Viemed Healthcare, Inc. (NASDAQ: VMD) will host its Q3 2025 Earnings Conference Call on November 6, 2025, at 11:00 a.m. ET, with a replay available on their website afterward.
Why It Matters
The upcoming earnings call provides insights into Viemed's financial performance and future outlook, crucial for assessing its investment potential and market position.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Viemed Healthcare, Inc. (NASDAQ: VMD) has completed its share repurchase program, buying back 1,976,441 shares, about 5% of its total outstanding shares, as authorized on June 9, 2025.
Why It Matters
Viemed Healthcare's completion of its share repurchase program signals confidence in its financial health, potentially boosting stock prices and indicating management's commitment to shareholder value.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Viemed Healthcare, Inc. (NASDAQ: VMD) will host its Q2 2025 Earnings Conference Call on August 7, 2025, at 11:00 AM ET, featuring key executives and research analysts.
Why It Matters
Viemed Healthcare's Q2 2025 earnings call will provide insights into its financial performance and strategic direction, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About VMD Stock
What is Viemed Healthcare Inc.'s (VMD) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Viemed Healthcare Inc. (VMD) has a median price target of $13.00. The highest price target is $15.00 and the lowest is $11.00.
Is VMD stock a good investment in 2026?
According to current analyst ratings, VMD has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.33. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VMD stock?
Wall Street analysts predict VMD stock could reach $13.00 in the next 12 months. This represents a 77.4% increase from the current price of $7.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Viemed Healthcare Inc.'s business model?
Viemed Healthcare Inc. operates by delivering personalized healthcare solutions for patients with chronic respiratory conditions, primarily generating revenue through in-home care services like disease management and ventilator therapy. The company ensures continuity of care beyond traditional clinical settings, thereby positioning itself as a vital provider in the home healthcare sector.
What is the highest forecasted price for VMD Viemed Healthcare Inc.?
The highest price target for VMD is $15.00 from at , which represents a 104.6% increase from the current price of $7.33.
What is the lowest forecasted price for VMD Viemed Healthcare Inc.?
The lowest price target for VMD is $11.00 from at , which represents a 50.1% increase from the current price of $7.33.
What is the overall VMD consensus from analysts for Viemed Healthcare Inc.?
The overall analyst consensus for VMD is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $13.00.
How accurate are VMD stock price projections?
Stock price projections, including those for Viemed Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 4:04 AM UTC